Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Scorpion toxin peptide BMK86-P1 achieves mutation-reversible inhibition of KCNA2 at the cost of reduced efficacy in heteromers and murine neurons.

Created on 28 Oct 2026

Authors

Elisabeth M M Brand, Lorenz Over, Hubert Kalbacher, Remy Lambert, Stefano Iavarone, Hang Lyu, Ulrike B S Hedrich, Peter Müller-Wöhrstein

Published in

Frontiers in pharmacology. Volume 17. Pages 1949571. Epub Oct 13, 2026.

Abstract

The discovery of distinctive function-phenotype relationships in monogenetic channelopathies has turned out to be critical for the development of precision medicine approaches. However, the most accurate prediction of clinical phenotypes depends on neuronal function, where existing models lack tools to isolate currents of individual voltage-gated potassium channel subunits and to differentiate variant effects in complex systems. Ideally, one should be able to overexpress subunit variants with an additional mutation that would confer resistance against the tool used to isolate the variant effect. Therefore, we solid-phase synthesized the KV1.2 specific scorpion toxin peptide BMK86-P1 and oxidized it with modest efficacy. In mammalian cells this BMK86-P1 selectively inhibited KV1.2 homomers, but not heteromers with KV1.1. Critically, the KCNA2 p. Val381Tyr mutation, which reverses BMK86-P1's selective inhibition of KV1.2, also altered the activation of KV1.2 homomers to resemble those of KV1.1. In addition, in murine neurons, BMK86-P1 did not alter passive membrane properties, single action potential properties, or action potential firing. Surprisingly, it induced only minimal changes in spontaneous excitatory postsynaptic currents. In summary, this KV1.2 subunit selective toxin peptide primarily affects homomeric channels, while only weakly inhibiting KV1.2/KV1.1 heteromeric channels and consequently preventing any meaningful impact on neuronal function. This highlights the limitations of peptide synthesis together with the need for testing specific compounds on complex systems.

PMID:
42947869
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement